from Reuters: Health News https://ift.tt/2UitLxb
Novavax shares plunge 65 percent as respiratory vaccine fails in late-stage trial
Novavax Inc shares crashed 65 percent on Thursday after data showed its vaccine failed to prevent RSV disease, a leading cause of respiratory infections in infants, missing the main goal of a late-stage study.
from Reuters: Health News https://ift.tt/2UitLxb
from Reuters: Health News https://ift.tt/2UitLxb
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment